Nazan Demir
Overview
Explore the profile of Nazan Demir including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
35
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gokmen I, Demir N, Peker P, Ozcan E, Akgul F, Bayrakci I, et al.
Front Oncol
. 2024 Dec;
14:1431629.
PMID: 39703857
Objective: The aim of our study was to assess the impact of the combination of HALP score with TTCR score on OS and PFS in PC patients who developed castration...
2.
Gokmen I, Tastekin E, Demir N, Ozcan E, Akgul F, Hacioglu M, et al.
Curr Issues Mol Biol
. 2023 Oct;
45(10):7803-7812.
PMID: 37886935
The aim of our study was to evaluate the incidence of KRAS/NRAS and BRAF mutations, analyze molecular patterns, and investigate associations with clinical parameters of these mutations in CRC KRAS/NRAS...
3.
Erol C, Sakin A, Basoglu T, Ozden E, Cabuk D, Dogan M, et al.
Turk J Med Sci
. 2022 Nov;
52(4):1022-1032.
PMID: 36326360
Background: Perioperative FLOT regimen is a standard of care in locally advanced operable gastric and GEJ adenocarcinoma. We aimed to determine the efficacy, prognostic factors of perioperative FLOT chemotherapy in...
4.
Basoglu T, Sakin A, Erol C, Ozden E, Cabuk D, Cilbir E, et al.
J Chemother
. 2022 May;
35(2):142-149.
PMID: 35579894
Neoadjuvant chemotherapy (NACT) in gastroesophageal junction (GEJ) and gastric cancer (GC) was shown to improve survival in recent studies. We aimed to share our real-life experience of patients who received...
5.
Atci M, Akagunduz B, Demir M, Arikan R, Ay S, Ozer M, et al.
J Chemother
. 2022 Feb;
35(1):19-28.
PMID: 35174772
The aim of this multicentre retrospective study was to compare the efficacy of adjuvant chemotherapy regimens both with and without oxaliplatin and tumor sidedness in stage IIB (pT4aN0) colon cancer...
6.
Garbioglu D, Demir N, Ozel C, Avci H, Dincer M
FASEB J
. 2021 Aug;
35(9):e21834.
PMID: 34403553
Two distinct genetic mutational pathways characterized by either chromosomal instability or high-frequency microsatellite instability (MSI-H) are recognized in the pathogenesis of colorectal cancer (CRC). Recently, it has been shown that...
7.
Duzgun E, Demir N, Alkan A, Dogan C, Cakir A
Clin Exp Optom
. 2021 May;
105(3):326-332.
PMID: 33938383
Clinical Relevance: Optical coherence tomography angiography (OCT-A) may enable the identification of alteration in the retinochoroidal microvasculature in patients with iron deficiency anaemia. Background: To investigate the presence of macular...
8.
Ozturkmen Y, Avci S, Calim A, Cetin E, Demir N, Mazi E, et al.
Sisli Etfal Hastan Tıp Bul
. 2020 Dec;
54(4):416-423.
PMID: 33364880
Objectives: The present study aims to compare different types of insulin concerning treatment success and insulin dose requirement in type 2 diabetes patients who were receiving basal-bolus insulin therapy and...
9.
Cetin E, Demir N, Sen I
Sisli Etfal Hastan Tıp Bul
. 2020 Dec;
54(4):411-415.
PMID: 33364879
Objectives: Non-alcoholic fatty liver disease (NAFLD) is closely associated with diseases, such as obesity, diabetes mellitus, metabolic syndrome, which are characterized by insulin resistance. NAFLD is thought to be a...
10.
Demir N, Yucelen S, Cetin E, Erol Kalkan K, Ozturkmen Y, Demir E, et al.
Sisli Etfal Hastan Tıp Bul
. 2020 Dec;
54(3):357-363.
PMID: 33312036
Objectives: Warfarin is the most frequently used therapy as an oral anticoagulant medication for reducing the risk of thromboembolic complications. However, poor adherence to therapy may cause ineffective INR levels...